Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog(®) in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis

INTRODUCTION: We evaluated the efficacy and safety of ultra-rapid lispro (URLi) in comparison to lispro in a subgroup analysis of Japanese adults with type 1 diabetes mellitus from the phase 3 PRONTO-T1D trial. METHODS: After an 8-week lead-in to optimize basal insulin treatment, patients were rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Junnosuke, Imori, Makoto, Nishiyama, Hiroshi, Imaoka, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435141/
https://www.ncbi.nlm.nih.gov/pubmed/32728832
http://dx.doi.org/10.1007/s13300-020-00892-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435141/
https://www.ncbi.nlm.nih.gov/pubmed/32728832
http://dx.doi.org/10.1007/s13300-020-00892-0

Ejemplares similares